AI Summary18 Sept 20267 Rabiʻ II 1448 AH
AI Summary
18 Sept 20267 Rabiʻ II 1448 AH
ByteDance spin-off Anew Labs raises US$290m as AI drug developers enjoy fundraising boom
China is experiencing a new fundraising surge for AI-powered drug development firms, with start-ups like Anew Labs raising hundreds of millions this week.
Anew Labs, based in Shanghai and a former unit of ByteDance, has secured $290 million at a valuation of $1.5 billion, showcasing the growing interest from investors.
This funding indicates a rising trend to support domestic challengers to companies like Anthropic and Isomorphic Labs, potentially boosting innovation in China's pharmaceutical sector.
Follow these topics
Sign in to follow the topics that matter to you
This summary is generated with AI and receives periodic editorial review. Refer to the original source for full details.
ByteDance spin-off Anew Labs raises US$290m as AI drug developers enjoy fundraising boom
China is experiencing a new fundraising surge for AI-powered drug development firms, with start-ups like Anew Labs raising hundreds of millions this week.
Anew Labs, based in Shanghai and a former unit of ByteDance, has secured $290 million at a valuation of $1.5 billion, showcasing the growing interest from investors.
This funding indicates a rising trend to support domestic challengers to companies like Anthropic and Isomorphic Labs, potentially boosting innovation in China's pharmaceutical sector.
Business
Follow these topics
Sign in to follow the topics that matter to you
This summary is generated with AI and receives periodic editorial review. Refer to the original source for full details.
0
0 reading now
Insight Score
Rate to unlock
You have not rated yet.
Sign in to react, rate, and save. Sign In
